» Articles » PMID: 22731250

SPRR2A Enhances P53 Deacetylation Through HDAC1 and Down Regulates P21 Promoter Activity

Overview
Journal BMC Mol Biol
Publisher Biomed Central
Specialty Molecular Biology
Date 2012 Jun 27
PMID 22731250
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Small proline rich protein (SPRR) 2A is one of 14 SPRR genes that encodes for a skin cross-linking protein, which confers structural integrity to the cornified keratinocyte cell envelope. New evidence, however, shows that SPRR2A is also a critical stress and wound repair modulator: it enables a variety of barrier epithelia to transiently acquire mesenchymal characteristics (EMT) and simultaneously quench reactive oxygen species during wound repair responses. p53 is also widely recognized as the node in cellular stress responses that inhibits EMT and triggers cell-cycle arrest, apoptosis, and cellular senescence. Since some p53-directed processes would seem to impede wound repair of barrier epithelia, we hypothesized that SPRR2A up regulation might counteract these effects and enable/promote wound repair under stressful environmental conditions.

Results: Using a well characterized cholangiocarcinoma cell line we show that levels of SPRR2A expression, similar to that seen during stressful biliary wound repair responses, disrupts acetylation and subsequent p53 transcriptional activity. p53 deacetylation is accomplished via two distinct, but possibly related, mechanisms: 1) a reduction of p300 acetylation, thereby interfering with p300-p53 binding and subsequent p300 acetylation of K382 in p53; and 2) an increase in histone deacetylase 1 (HDAC1) mRNA and protein expression. The p300 CH3 domain is essential for both the autoacetylation of p300 and transference of the acetyl group to p53 and HDAC1 is a component of several non-p300 complexes that enhance p53 deacetylation, ubiquitination, and proteosomal degradation. HDAC1 can also bind the p300-CH3 domain, regulating p300 acetylation and interfering with p300 mediated p53 acetylation. The importance of this pathway is illustrated by showing complete restoration of p53 acetylation and partial restoration of p300 acetylation by treating SPRR2A expressing cells with HDAC1 siRNA.

Conclusion: Up-regulation of SPRR2A, similar to that seen during barrier epithelia wound repair responses reduces p53 acetylation by interfering with p300-p53 interactions and by increasing HDAC1 expression. SPRR2A, therefore, functions as a suppressor of p53-dependent transcriptional activity, which otherwise might impede cellular processes needed for epithelial wound repair responses such as EMT.

Citing Articles

Peptidase Inhibitor 16 Attenuates Left Ventricular Injury and Remodeling After Myocardial Infarction by Inhibiting the HDAC1-Wnt3a-β-Catenin Signaling Axis.

Wang L, Du A, Lu Y, Zhao Y, Qiu M, Su Z J Am Heart Assoc. 2023; 12(10):e028866.

PMID: 37158154 PMC: 10227313. DOI: 10.1161/JAHA.122.028866.


[Screening, functional analysis and clinical validation of differentially expressed genes in diabetic foot ulcers].

Wang P, Chen Z, Jiang L, Zhou X, Jia C, Xiao H Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022; 38(10):944-951.

PMID: 36299206 PMC: 11821333. DOI: 10.3760/cma.j.cn501225-20220731-00328.


Epigenetic Alterations of DNA Methylation and miRNA Contribution to Lung Adenocarcinoma.

Cai W, Jing M, Wen J, Guo H, Xue Z Front Genet. 2022; 13:817552.

PMID: 35711943 PMC: 9194831. DOI: 10.3389/fgene.2022.817552.


The 1q21.3 region driver gene promotes disease progression via inhibition of lung adenocarcinoma cell apoptosis.

Dong C, Li P, Wu Y, Guo Z, He R Transl Cancer Res. 2022; 11(5):1309-1320.

PMID: 35706812 PMC: 9189215. DOI: 10.21037/tcr-22-979.


DEK modulates both expression and alternative splicing of cancer‑related genes.

Liu B, Sun Y, Zhang Y, Xing Y, Suo J Oncol Rep. 2022; 47(6).

PMID: 35475534 PMC: 9073418. DOI: 10.3892/or.2022.8322.


References
1.
Levine A . p53, the cellular gatekeeper for growth and division. Cell. 1997; 88(3):323-31. DOI: 10.1016/s0092-8674(00)81871-1. View

2.
Kim T, Veronese A, Pichiorri F, Lee T, Jeon Y, Volinia S . p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med. 2011; 208(5):875-83. PMC: 3092351. DOI: 10.1084/jem.20110235. View

3.
Nozaki I, Lunz 3rd J, Specht S, Stolz D, Taguchi K, Subbotin V . Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation. Lab Invest. 2004; 85(1):109-23. DOI: 10.1038/labinvest.3700213. View

4.
Ito A, Kawaguchi Y, Lai C, Kovacs J, Higashimoto Y, Appella E . MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 2002; 21(22):6236-45. PMC: 137207. DOI: 10.1093/emboj/cdf616. View

5.
Grossman S, Deato M, Brignone C, Chan H, Kung A, Tagami H . Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science. 2003; 300(5617):342-4. DOI: 10.1126/science.1080386. View